User menu

Efficacy of Oral C5aR Inhibitor CCX168 on Non-Renal Disease Activity in Patients withAntineutrophil Cytoplasmic Antibody-Associated Vasculitis

Bibliographic reference Jayne, David RW ; Bruchfeld, Annette ; Schaier, Matthias ; Jadoul, Michel ; Segelmark, Marten ; et. al. Efficacy of Oral C5aR Inhibitor CCX168 on Non-Renal Disease Activity in Patients withAntineutrophil Cytoplasmic Antibody-Associated Vasculitis.American Society of Nephrology (Philadelphia, du 11/11/2014 au 16/11/2014). In: American Society of Nephrology Renal Week 2014, 2014
Permanent URL http://hdl.handle.net/2078.1/153268